Pain Perception Due To Orthodontic Separator With And Without Diclofenac Mouthwash

Singla, Ritesh and Singla, Nishu (2014) Pain Perception Due To Orthodontic Separator With And Without Diclofenac Mouthwash. Journal of International Academic Research for Multidisciplinary, 2 (2). pp. 475-486. ISSN 2320-5083

[img] PDF
original article.pdf - Published Version
Restricted to Registered users only

Download (65kB) | Request a copy

Abstract

Pain is defined as an unpleasant emotional experience usually initiated by a noxious stimulus and transmitted over a specialized neural network to the central nervous system where it is interpreted as such. Pain is an important reason that refrain patients from seeking orthodontic care. So the control of pain during orthodontic treatment is important to both orthodontists and patients Pain is common after the placement of separators and it increases to a significant level of discomfort at 4 and 24 hours after insertion of separators. Systemic effects of NSAIDs have been reported due to administration of oral drugs. In this study, use of Diclofenac mouthwash to alleviate orthodontic pain has been hypothesized to overcome those systemic effects.Thus the purpose of this prospective clinical study was, to assess the effectiveness of Diclofenac mouthwash in reducing the incidence and severity of pain after orthodontic separator placement. AIMS AND OBJECTIVES: • The purpose of this prospective clinical study is, to assess the effectiveness of Diclofenac mouthwash in reducing the incidence and severity of pain after orthodontic separator placement. • To know the efficacy of Diclofenac in controlling pain associated with orthodontic separator placement. • To determine the difference in control of pain between Diclofenac and the placebo in each patient. METHODOLOGY: A total of 30 patients with age between 15-25 years will be included in this randomized, single blind, placebo controlled, and prospective study. Patients mouth will be divided to 3 different quadrants. Quadrant. I .In the first quadrant with control group (with no medication) after separator placement patient’s level of discomfort will be assessed with a Wong baker faces pain rating scale daily and will be followed by for 3 consecutive, subsequently followed by a wash period of 3 days . Quadrant.II. After separator placement in the second quadrant, 15ml of undiluted Diclofenac mouthwash will be given thrice daily for 3 consecutive days, subsequently followed by a wash period of 3days. QuadrantT.III. After separator placement in the second quadrant, placebo mouthwash will be given thrice daily for 3 consecutive days, subsequently followed by a wash period of 3 days. RESULTS: • The mean pain scores for control group on the first day was 2.33±0.81, second day was 2.11±0.96 and on third day was 1.31±0.77. • The mean pain score for Placebo group on first day was 1.73±0.72, second day was 1.22±0.75 and on third day was 0.71±0.51. • The mean pain score for Diclofenac group on first day was 1.64±0.61, second day was 1.08±0.65 and on third day was 0.44±0.47. Comparison of three groups with respect to pain scores was done using one way ANOVA. • The scores for first day between the groups and within the groups was significant with the p-value 0.0006. • The scores for second day between the groups and within the groups was significant with the p-value 0.0000. • The scores for third day between the groups and within the groups was significant with the p-value 0.0000. Pair wise comparison of three groups with respect to pain scores at 1st day, 2nd day and 3rd day treatment time was done using Duncans multiple posthoc procedure. On the 1st day a statistically significant difference was observed between the control and Diclofenac group(p=0.0006)& control and placebo group(p=0.00018)where as a non significant difference was observed between placebo and diclofenac group(p=0.6325). On the 2nd day a statistically significant difference was observed between the control and Diclofenac group(p=0.0001)& control and placebo group(p=0.0002)where as a non significant difference was observed between placebo and diclofenac group(p=0.4870). On the 3rd day a statistically significant difference was observed between the control and Diclofenac group(p=0.0001)& control and placebo group(p=0.0009)where as a non significant difference was observed between placebo and diclofenac group(p=0.1240). CONCLUSION Diclofenac mouth wash found to be significantly effective in reduction of incidence and severity of pain after orthodontic separator placement. It was found to be significantly more effective in controlling the pain after separator placement. When compared to the placebo. Placebo group also showed a decrease in intensity of pain compared to the control group. Due to psychological adaptation or because of alteration in the pain threshold making patient resistant it pain sensation. This approach to managing pain during orthodontic treatment warrants further investigation with larger sample size and contribution of gender and age to the same.

Item Type: Article
Subjects: Dentistry > MCODS Manipal > Preventive and Community Dentistry
Dentistry > MCODS Manipal > Orthodontics
Depositing User: KMC Manipal
Date Deposited: 07 May 2014 11:14
Last Modified: 07 May 2014 11:14
URI: http://eprints.manipal.edu/id/eprint/139493

Actions (login required)

View Item View Item